Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Revenue: 2019-2024

Historic Revenue for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Dec 2024 value amounting to $714.7 million.

  • Harmony Biosciences Holdings' Revenue rose 28.71% to $239.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $825.9 million, marking a year-over-year increase of 21.13%. This contributed to the annual value of $714.7 million for FY2024, which is 22.80% up from last year.
  • Harmony Biosciences Holdings' Revenue amounted to $714.7 million in FY2024, which was up 22.80% from $582.0 million recorded in FY2023.
  • Harmony Biosciences Holdings' 5-year Revenue high stood at $714.7 million for FY2024, and its period low was $159.7 million during FY2020.
  • Over the past 3 years, Harmony Biosciences Holdings' median Revenue value was $582.0 million (recorded in 2023), while the average stood at $578.2 million.
  • Data for Harmony Biosciences Holdings' Revenue shows a peak YoY skyrocketed of 2,564.59% (in 2020) over the last 5 years.
  • Over the past 5 years, Harmony Biosciences Holdings' Revenue (Yearly) stood at $159.7 million in 2020, then skyrocketed by 91.21% to $305.4 million in 2021, then surged by 43.35% to $437.9 million in 2022, then surged by 32.93% to $582.0 million in 2023, then increased by 22.80% to $714.7 million in 2024.